Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26439489
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 PLoS+One
2015 ; 10
(10
): e0139694
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
The Progressive BSSG Rat Model of Parkinson s: Recapitulating Multiple Key
Features of the Human Disease
#MMPMID26439489
Van Kampen JM
; Baranowski DC
; Robertson HA
; Shaw CA
; Kay DG
PLoS One
2015[]; 10
(10
): e0139694
PMID26439489
show ga
The development of effective neuroprotective therapies for Parkinson's disease
(PD) has been severely hindered by the notable lack of an appropriate animal
model for preclinical screening. Indeed, most models currently available are
either acute in nature or fail to recapitulate all characteristic features of the
disease. Here, we present a novel progressive model of PD, with behavioural and
cellular features that closely approximate those observed in patients. Chronic
exposure to dietary phytosterol glucosides has been found to be neurotoxic. When
fed to rats, ?-sitosterol ?-d-glucoside (BSSG) triggers the progressive
development of parkinsonism, with clinical signs and histopathology beginning to
appear following cessation of exposure to the neurotoxic insult and continuing to
develop over several months. Here, we characterize the progressive nature of this
model, its non-motor features, the anatomical spread of synucleinopathy, and
response to levodopa administration. In Sprague Dawley rats, chronic BSSG feeding
for 4 months triggered the progressive development of a parkinsonian phenotype
and pathological events that evolved slowly over time, with neuronal loss
beginning only after toxin exposure was terminated. At approximately 3 months
following initiation of BSSG exposure, animals displayed the early emergence of
an olfactory deficit, in the absence of significant dopaminergic nigral cell loss
or locomotor deficits. Locomotor deficits developed gradually over time,
initially appearing as locomotor asymmetry and developing into
akinesia/bradykinesia, which was reversed by levodopa treatment. Late-stage
cognitive impairment was observed in the form of spatial working memory deficits,
as assessed by the radial arm maze. In addition to the progressive loss of TH+
cells in the substantia nigra, the appearance of proteinase K-resistant
intracellular ?-synuclein aggregates was also observed to develop progressively,
appearing first in the olfactory bulb, then the striatum, the substantia nigra
and, finally, hippocampal and cortical regions. The slowly progressive nature of
this model, together with its construct, face and predictive validity, make it
ideal for the screening of potential neuroprotective therapies for the treatment
of PD.